John B. Bode

Insider Reports History

Entity
Individual
Location
C/O Tribune Publishing Company, 202 W. First Street, Los Angeles, CA
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Bode:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FISION Corp Director Common Stock 10.5M $231K $0.02 Nov 30, 2021 Direct
ZEVRA THERAPEUTICS, INC. Director Common Stock 30K $176K $5.87 Jul 12, 2024 Direct
ZEVRA THERAPEUTICS, INC. Director Stock Option (right to buy) 39.2K May 13, 2024 Direct

Insider Reports Filed by John B. Bode

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZVRA ZEVRA THERAPEUTICS, INC. Jul 12, 2024 1 $58.7K 4 Jul 15, 2024 Director
ZVRA ZEVRA THERAPEUTICS, INC. May 13, 2024 1 $0 4 May 15, 2024 Director
SGRP SPAR Group, Inc. Oct 1, 2023 0 $0 3 Dec 1, 2023 Director
ZVRA ZEVRA THERAPEUTICS, INC. Sep 5, 2023 1 $51.3K 4 Sep 6, 2023 Director
ZVRA ZEVRA THERAPEUTICS, INC. May 18, 2023 6 $50.4K 4 May 19, 2023 Director
ZVRA ZEVRA THERAPEUTICS, INC. May 3, 2023 1 $0 4 May 8, 2023 Director
ZVRA ZEVRA THERAPEUTICS, INC. Apr 25, 2023 0 $0 3 May 8, 2023 Director
FSSN FISION Corp May 31, 2021 3 $37.5K 4 Dec 28, 2021 Director